1. Home
  2. GMM vs STRO Comparison

GMM vs STRO Comparison

Compare GMM & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Mofy Metaverse Limited

GMM

Global Mofy Metaverse Limited

HOLD

Current Price

$1.16

Market Cap

76.8M

Sector

N/A

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

N/A

Current Price

$18.50

Market Cap

85.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GMM
STRO
Founded
2017
2003
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.8M
85.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
GMM
STRO
Price
$1.16
$18.50
Analyst Decision
Hold
Analyst Count
0
8
Target Price
N/A
$18.88
AVG Volume (30 Days)
166.5K
117.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$63.08
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.94
$0.52
52 Week High
$4.75
$19.90

Technical Indicators

Market Signals
Indicator
GMM
STRO
Relative Strength Index (RSI) 46.02 65.21
Support Level $1.04 $0.73
Resistance Level $3.18 N/A
Average True Range (ATR) 0.15 1.84
MACD 0.01 0.12
Stochastic Oscillator 17.28 76.17

Price Performance

Historical Comparison
GMM
STRO

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital asset development for the metaverse industry. The Company leverages its proprietary Mofy Lab technology platform, which integrates three-dimensional (3D) reconstruction technology and artificial intelligence (AI) interactive technology, to create high-definition virtual versions of physical world objects, including humans, animals, and scenes. It provides comprehensive technology solutions to support virtual content production for use across movies, television series, animation, advertising, and gaming. The Company operates through Virtual Technology Services, which generates the majority of revenue, and Digital Asset Development and others.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: